{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:46:25Z","timestamp":1762508785636,"version":"build-2065373602"},"reference-count":44,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T00:00:00Z","timestamp":1656720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005632","name":"National Centre For Research and Development","doi-asserted-by":"publisher","award":["SZPITALE-JEDNOIMIENNE\/27\/2020"],"award-info":[{"award-number":["SZPITALE-JEDNOIMIENNE\/27\/2020"]}],"id":[{"id":"10.13039\/501100005632","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Introduction: Thromboembolic events, including mainly pulmonary embolisms and ischemic strokes, occur in up to one-third of COVID-19 patients. As efficacy of tocilizumab (TCZ) among patients with acute pulmonary embolism (PE) was not previously investigated, this study aimed to provide such data. Objectives: The aim of the study was to investigate the effect of TCZ on mortality in patients with confirmed acute pulmonary embolism, cytokine release storm and COVID-19 pneumonia. Patients and methods: Longitudinal data of 4287 patients with confirmed SARS-CoV-2 infection were collected between 4 March 2020 and 16 January 2022. In this study, we retrospectively analyzed the samples and dataset of cases with confirmed acute pulmonary embolism associated with at least moderate lung involvement due to COVID-19 pneumonia. Results: In the analyzed dataset, 64 adult patients were diagnosed with PE, and of these, 28 (44%) cases were treated with two 8 mg\/kg doses of TCZ, and 36 (56%) did not receive this agent. The groups were balanced regarding demographics, comorbidities and the biochemical markers. Overall mortality in our study was 29.6% (n = 17). Mortality in the group treated with TCZ was 43% (n = 12) compared to 19% (n = 7) in the group without TCZ. In multivariate proportional Cox hazards models, intravenous administration of TCZ was independently associated with higher mortality (HR: 3.342 (CI: 1.077\u201310.370), p = 0.036). Conclusions: In patients with COVID-19 pneumonia with at least moderate lung involvement, CRS and acute pulmonary embolism, administration of TCZ is associated with increased mortality. Therefore, TCZ should be used with caution in SARS-CoV-2 cases with pulmonary embolism.<\/jats:p>","DOI":"10.3390\/biomedicines10071581","type":"journal-article","created":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T11:12:35Z","timestamp":1656760355000},"page":"1581","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Tocilizumab Use among Patients Who Developed Pulmonary Embolism in the Course of Cytokine Release Storm and COVID-19 Pneumonia\u2014A Retrospective Study"],"prefix":"10.3390","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6775-4152","authenticated-orcid":false,"given":"Daniel","family":"Chober","sequence":"first","affiliation":[{"name":"Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 71-455 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2092-3737","authenticated-orcid":false,"given":"Bogusz","family":"Aksak-W\u0105s","sequence":"additional","affiliation":[{"name":"Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 71-455 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolanta","family":"Ni\u015bcigorska-Olsen","sequence":"additional","affiliation":[{"name":"Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 71-455 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ma\u0142gorzata","family":"Niekrasz","sequence":"additional","affiliation":[{"name":"Department of Neurology, Regional Hospital in Szczecin, 71-455 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1869-1084","authenticated-orcid":false,"given":"Mi\u0142osz","family":"Parczewski","sequence":"additional","affiliation":[{"name":"Department of Infectious, Tropical Diseases and Immune Deficiency, Pomeranian Medical University in Szczecin, 71-455 Szczecin, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.115.306841","article-title":"Global Burden of Thrombosis: Epidemiologic Aspects","volume":"118","author":"Wendelboe","year":"2016","journal-title":"Circ. Res."},{"key":"ref_2","first-page":"785","article-title":"Thrombosis and platelets: An update","volume":"38","author":"Koupenova","year":"2017","journal-title":"Eur. Heart J."},{"key":"ref_3","first-page":"831","article-title":"Time trends in pulmonary embolism in the United States: Evidence of overdiagnosis","volume":"171","author":"Wiener","year":"2011","journal-title":"Arch. Intern. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s11239-009-0396-1","article-title":"Incidence rate of pulmonary embolism in Germany: Data from the federal statistical office","volume":"29","author":"Moerchel","year":"2010","journal-title":"J. Thromb. Thrombolysis"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1111\/j.1538-7836.2009.03408.x","article-title":"Short-term prognosis of pulmonary embolism","volume":"7","author":"Aujesky","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.amjcard.2004.01.058","article-title":"Estimated case fatality rate of pulmonary embolism, 1979 to 1998","volume":"93","author":"Stein","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/CIRCULATIONAHA.107.726232","article-title":"Clinical predictors for fatal pulmonary embolism in 15,520 patients with venous thromboembolism: Findings from the Registro Informatizado de la Enfermedad TromboEmbolica venosa (RIETE) Registry","volume":"117","author":"Laporte","year":"2008","journal-title":"Circulation"},{"key":"ref_8","unstructured":"(2022, March 12). WHO Coronavirus (COVID-19) Dashboard|WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. Available online: https:\/\/covid19.who.int\/."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1038\/s41598-021-82862-5","article-title":"Causes of death and comorbidities in hospitalized patients with COVID-19","volume":"11","author":"Elezkurtaj","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/thoraxjnl-2020-215383","article-title":"Arterial and venous thromboembolism in COVID-19: A study-level meta-analysis","volume":"76","author":"Tan","year":"2021","journal-title":"Thorax"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1358863X21995566","article-title":"Venous thromboembolism in COVID-19: A systematic review and meta-analysis","volume":"26","author":"Kollias","year":"2021","journal-title":"Vasc. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/ajh.25982","article-title":"Thrombosis in COVID-19","volume":"95","author":"Hanff","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review","volume":"75","author":"Bikdeli","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s11739-020-02621-8","article-title":"Arterial and venous thrombosis in coronavirus 2019 disease (COVID-19): Relationship with mortality","volume":"16","author":"Violi","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"E70","DOI":"10.1148\/radiol.2020203557","article-title":"Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis","volume":"298","author":"Suh","year":"2021","journal-title":"Radiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e200067","DOI":"10.1148\/ryct.2020200067","article-title":"COVID-19 complicated by acute pulmonary embolism","volume":"2","author":"Xie","year":"2020","journal-title":"Radiol. Cardiothorac. Imaging"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.avsg.2020.08.087","article-title":"Arterial Thrombosis in Coronavirus Disease 2019 Patients: A Rapid Systematic Review","volume":"70","author":"Cheruiyot","year":"2021","journal-title":"Ann. Vasc. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/neurintsurg-2020-016794","article-title":"Ischemic stroke in COVID-19-positive patients: An overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist","volume":"13","author":"Zakeri","year":"2021","journal-title":"J. Neurointerv. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"The RECOVERY Collaborative Group (2021). Dexamethasone in Hospitalized Patients with COVID-19. N. Engl. J. Med., 384, 693\u2013704.","DOI":"10.1056\/NEJMoa2021436"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.33963\/KP.a2021.0154","article-title":"COVID-19 and thrombosis: Clinical features, mechanism of disease, and therapeutic implications","volume":"79","author":"Violi","year":"2021","journal-title":"Kardiol. Pol. (Pol. Heart J.)"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1093\/eurheartj\/ehaa623","article-title":"COVID-19 is, in the end, an endothelial disease","volume":"41","author":"Libby","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1016\/S2352-3026(20)30215-5","article-title":"Endothelial cells orchestrate COVID-19 coagulopathy","volume":"7","author":"Gonagle","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_24","first-page":"259","article-title":"Severe systemic thrombosis in a young COVID-19 patient with a rare homozygous prothrombin G20210A mutation","volume":"29","author":"Fiore","year":"2021","journal-title":"Infez Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): A randomised, controlled, open-label, platform trial","volume":"397","author":"Abani","year":"2021","journal-title":"Lancet"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Chober, D., Aksak-W\u0105s, B., Bobrek-Lesiakowska, K., Budny-Finster, A., Ho\u0142da, E., Mie\u017cy\u0144ska-Kurtycz, J., Jamro, G., and Parczewski, M. (2022). Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study. J. Clin. Med., 11.","DOI":"10.3390\/jcm11092286"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jaci.2020.05.008","article-title":"Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19","volume":"146","author":"Herold","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12959-020-00236-9","article-title":"Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: A Fa\u00e7ade for prognostic markers","volume":"18","author":"Atallah","year":"2020","journal-title":"Thromb. J."},{"key":"ref_29","first-page":"e15208","article-title":"Tocilizumab and Thromboembolism in COVID-19: A Retrospective Hospital-Based Cohort Analysis","volume":"15","author":"Chan","year":"2021","journal-title":"Cureus"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1182\/blood-2020-137707","article-title":"Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients","volume":"136","author":"Warrior","year":"2020","journal-title":"Blood"},{"key":"ref_31","first-page":"487","article-title":"Management of SARS-CoV-2 infection: Recommendations of the Polish Association of Epidemiologists and Infectiologists as of April 26, 2021","volume":"131","author":"Flisiak","year":"2021","journal-title":"Polish Arch. Intern. Med."},{"key":"ref_32","first-page":"16140","article-title":"Diagnosis and therapy of SARS-CoV-2 infection: Recommendations of the polish association of epidemiologists and infectiologists as of November 12, 2021","volume":"131","author":"Flisiak","year":"2021","journal-title":"Polish Arch. Intern. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1007\/s00330-020-06865-y","article-title":"COVID-19 patients and the radiology department\u2014Advice from the European Society of Radiology (ESR) and the European Society of Thoracic Imaging (ESTI)","volume":"30","author":"Revel","year":"2020","journal-title":"Eur. Radiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.diii.2020.06.001","article-title":"Chest CT in COVID-19 pneumonia: A review of current knowledge","volume":"101","author":"Jalaber","year":"2020","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_35","first-page":"352","article-title":"Management of SARS-CoV-2 infection: Recommendations of the Polish Association of Epidemiologists and Infectiologists as of March 31, 2020","volume":"130","author":"Flisiak","year":"2020","journal-title":"Polish Arch. Intern. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/jth.14830","article-title":"Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia","volume":"18","author":"Cui","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1111\/jth.14888","article-title":"Incidence of venous thromboembolism in hospitalized patients with COVID-19","volume":"18","author":"Middeldorp","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: A multicenter prospective cohort study","volume":"46","author":"Helms","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/jth.14869","article-title":"High incidence of venous thromboembolic events in anticoagulated severe COVID-19 patients","volume":"18","author":"Llitjos","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.thromres.2020.04.041","article-title":"Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis","volume":"191","author":"Klok","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/CIRCULATIONAHA.120.046702","article-title":"Deep Vein Thrombosis in Hospitalized Patients with COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome","volume":"142","author":"Zhang","year":"2020","journal-title":"Circulation"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1186\/s13063-020-04475-z","article-title":"Randomised controlled trial comparing efficacy and safety of high versus low Low-Molecular Weight Heparin dosages in hospitalized patients with severe COVID-19 pneumonia and coagulopathy not requiring invasive mechanical ventilation (COVID-19 HD): A structured summary of a study protocol","volume":"21","author":"Marietta","year":"2020","journal-title":"Trials"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1055\/a-1347-6070","article-title":"Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: The Multicenter Italian CORIST Study","volume":"121","author":"Costanzo","year":"2021","journal-title":"Thromb. Haemost."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"162","DOI":"10.14740\/jh836","article-title":"Incidence of Venous Thromboembolism and Effect of Anticoagulant Dosing in Hospitalized COVID-19 Patients","volume":"10","author":"Kumar","year":"2021","journal-title":"J. Hematol."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1581\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:42:10Z","timestamp":1760139730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/10\/7\/1581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,2]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["biomedicines10071581"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines10071581","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2022,7,2]]}}}